At ThermoCap Laboratories, we are revolutionizing the collection and interpretation of DSC data. Our proprietary, next generation DSC technology is called Direct Ratiometric Calorimetry (DRC) and our tools are tailor-made to improve drug discovery and screening.
Drug Screening Analysis: The ThermoCap platform employs DRC thermal analysis of proteins to evaluate drug binding. Our ratiometric method is extremely user-friendly and simple. It provides quantitative evaluation of both binding constants and binding stoichiometry of drug interactions to the target protein.
An additional advantage of our technology is our novel sample preparation methodology for testing and analysis of poor or insoluble drugs. Our protein-mediated process requires minimum amounts of drugs (milligrams) while avoiding the necessity (for solubility purposes) of organic solvents in drug/protein solutions.
Expression System Analysis: We have developed a unique DRC method utilizing DNA probes for determining unknown concentrations of biological molecules in both pure and impure solutions. Our probes are universally applicable to a wide range of biological molecules and enable mass quantification prior to purification. This advance allows for initial analysis of biologics early in the production process, lowering associated time requirements and resource costs.
RapiDRC: The RapiDRC is a calorimetry instrument currently in development at ThermoCap Labs and is specially designed to empower Direct Ratiometric Calorimetry processes. The RapiDRC is capable of processing 24-96 samples in parallel, using a single bench-top instrument. The speed and capabilities offered by this instrument will be a leap forward for applying calorimetry to drug discovery and health screening applications.
At ThermoCap Laboratories, we are revolutionizing the collection and interpretation of DSC data. Our proprietary, next generation DSC technology is called Direct Ratiometric Calorimetry (DRC) and our tools are tailor-made to improve drug discovery and screening.
Drug Screening Analysis: The ThermoCap platform employs DRC thermal analysis of proteins to evaluate drug binding. Our ratiometric method is extremely user-friendly and simple. It provides quantitative evaluation of both binding constants and binding stoichiometry of drug interactions to the target protein.
An additional advantage of our technology is our novel sample preparation methodology for testing and analysis of poor or insoluble drugs. Our protein-mediated process requires minimum amounts of drugs (milligrams) while avoiding the necessity (for solubility purposes) of organic solvents in drug/protein solutions.
Expression System Analysis: We have developed a unique DRC method utilizing DNA probes for determining unknown concentrations of biological molecules in both pure and impure solutions. Our probes are universally applicable to a wide range of biological molecules and enable mass quantification prior to purification. This advance allows for initial analysis of biologics early in the production process, lowering associated time requirements and resource costs.
RapiDRC: The RapiDRC is a calorimetry instrument currently in development at ThermoCap Labs and is specially designed to empower Direct Ratiometric Calorimetry processes. The RapiDRC is capable of processing 24-96 samples in parallel, using a single bench-top instrument. The speed and capabilities offered by this instrument will be a leap forward for applying calorimetry to drug discovery and health screening applications.
At ThermoCap Laboratories, we are revolutionizing the collection and interpretation of DSC data. Our proprietary, next generation DSC technology is called Direct Ratiometric Calorimetry (DRC) and our tools are tailor-made to improve drug discovery and screening.
Drug Screening Analysis: The ThermoCap platform employs DRC thermal analysis of proteins to evaluate drug binding. Our ratiometric method is extremely user-friendly and simple. It provides quantitative evaluation of both binding constants and binding stoichiometry of drug interactions to the target protein.
An additional advantage of our technology is our novel sample preparation methodology for testing and analysis of poor or insoluble drugs. Our protein-mediated process requires minimum amounts of drugs (milligrams) while avoiding the necessity (for solubility purposes) of organic solvents in drug/protein solutions.
Expression System Analysis: We have developed a unique DRC method utilizing DNA probes for determining unknown concentrations of biological molecules in both pure and impure solutions. Our probes are universally applicable to a wide range of biological molecules and enable mass quantification prior to purification. This advance allows for initial analysis of biologics early in the production process, lowering associated time requirements and resource costs.
RapiDRC: The RapiDRC is a calorimetry instrument currently in development at ThermoCap Labs and is specially designed to empower Direct Ratiometric Calorimetry processes. The RapiDRC is capable of processing 24-96 samples in parallel, using a single bench-top instrument. The speed and capabilities offered by this instrument will be a leap forward for applying calorimetry to drug discovery and health screening applications.